Nanexa AB Sustainability Reports
Nanexa AB is a pharmaceutical company that develops long-acting injectable drug products based on its proprietary PharmaShell drug delivery system. The company also operates a GMP-classed pilot manufacturing facility to produce clinical study materials independently.
Sector: Professional & technical services
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300J5L2ECZTLID491
FIGI: BBG008VJ17V5
5 reports from 2021 to 2025
